Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What do you guys think, is this run up due to InMed's recent news releases and interviews, or from the legalization talks in Canada?
Auditor? Not familiar, what does an auditor do and what does that mean for InMed?
Well the CEO said in an interview that "things are lining up for the EB drug to start clinical trials in Q3 of next year" so I don't think they'd be finished clinical trials by next fall. But maybe they'll have scaled up their biosynthesis to the point of selling cannabinoids to other companies. InMed has enormous potential, could be bigger than GW.
I'm Ric Flair! The Stylin', profilin', limousine riding, jet flying, kiss-stealing, wheelin' n' dealin' son of a gun! WOOOOOOO!
Anyone have full access to this article? Says I need to pay $25 to read the full thing.
In a past CEO interview he said they're laying out the path to becoming a world leader in the cannabis biotech industry. He also said when asked about partnering and/or licensing out their assets he said all of the above, "which ever is best for shareholder return" (or something along those lines).
http://www.cannabisfn.com/cfnvideo/?id=Dsey9qYk this is the interview I'm referring to.
It seems like he has the vision to be a world leader in cannabis biotech and has a shareholder friendly mindset, so I don't know if they would be agree to be bought out unless it was a really good return for shareholders because of the potential he sees in the company.
Saw that. Suzzad has millions of shares pretty sure so not worried about it. Probably just wanted some money
For anyone doubting the effectiveness of biosynthesized cannabinoids vs botanically sourced, here's an article about biosynthesized insulin vs the old extracted insulin.
http://www.chemistrylearning.com/humulin-synthetic-insulin/
Biosynthesis results in a purer molecule, meaning little to none foreign molecules associated with the desired product. So I'm thinking biosynthesized cannabinoids will be even more effective than botanically sourced cannabinoids due to higher purity.
For anyone doubting the effectiveness of biosynthesized cannabinoids vs botanically sourced, here's an article about biosynthesized insulin vs the old extracted insulin.
http://www.chemistrylearning.com/humulin-synthetic-insulin/
Biosynthesis results in a purer molecule, meaning little to none foreign molecules associated with the desired product. So I'm thinking biosynthesized cannabinoids will be even more effective than botanically sourced cannabinoids due to higher purity.
Google "medical miracle teaspoon seedinvestor", it should be the first link
That's weird, I can. Try copying and pasting it into the address bar.
The value of a cannabinoid
In case you haven't seen this article by The Seed Investor
http://theseedinvestor.com/research/medical-miracle-compound-report#
Sounds like biosynthesis has enormous potential
A little confused. AgriMed is a cultivation company? What could these companies do with InMed?
From the October presentation on their website it looks like they want a partner before going into clinical trials
InMed also has the VP Finance & Investment Banking guy from Eli Lilly so I think he will be a great asset in terms of raising money
I know that in the August presentation they said they had 2.7 million in cash and now they have 6.7 million so I assume this financing is happening. Not sure how this stuff works as Im not aware of a private placement happening right now.
Not sure about the 15 million financing, I can't find the article again. But CEO Eric Adams said on BNN that they don't need much resources for their EB drug to get through phase 1, and after phase 1 thats when he expects them to be on the NASDAQ.
Well wouldn't an INM-085 partner help finance clinical trials? Also I heard they are raising $15 million in the next two years. If you look at their presentation on inmedpharma.com, they have $6.7 million in cash.
Misread your post, my bad! Once they get the glaucoma patent I think they'll be able to quickly find a great partner.
Who would they like to have as a partner? I haven't read anything about this.
Difference between InMed's INM-085 and Axim's drug?
http://www.marketwired.com/press-release/axim-biotech-new-clinical-program-featured-national-ophthalmology-publication-reignites-otcqb-axim-2209406.htm
I just came across this and it looks like Axim's drug in development is very similar to InMed's for glaucoma. Not familiar with Axim, but does anyone know the difference in these two drug candidates?
"Wiith treatments already in the pipeline, this BioTech company is taking a unique and potentially REVOLUTIONARY approach to treating pain and potentially REVERSING major diseases through the power of Cann.abis.
And that has Execs from powerhouse Pharma & Biotech companies rushing to join the ride!"
Sure sounds like InMed to me. Thanks for posting!
Would you mind pasting the article here?
"Patents to be approved"
Scroll to the bottom of this link https://www.stockhouse.com/companies/bullboard?symbol=c.in&page=2 and you'll see that hotinfl is saying that patents are going to be approved. This guy was right about news coming out twice in the past as far as I've seen.
If the glaucoma patent is approved, InMed can probably easily find a great partner for their glaucoma drug. I'm thinking that if they get a partner for the drug, that partner may also fund the expansion of the biosynthesis into commercial scale to enable the production of the glaucoma drug. Just my thoughts but we'll see.
Shake n bake!
New article with CEO excerpts, drug candidates sound promising!
http://business.financialpost.com/news/inmed-pharmaceuticals-pursues-medical-qualities-of-cannabis-no-smoke
Biosynthesis for GW
Hey, new to the board and am a long shareholder. Was wondering if anyone knows how much GW Pharma or any other cannabis biotech might pay InMed to make cannabinoids for them. Also, how much might this affect share price? How many cents/dollars could InMed increase from this sort of deal?
Thanks for any input
GLTA!